Search

everythinglearnresearchcommunity

for

Search:↓

The electronic version of the Dermatology Life Quality Index is as effective as the paper version, with most patients preferring it.

Alopecia treatments improve life quality but side effects can lessen this benefit; better use of quality of life measures is needed.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

There is a significant need for better-validated quality of life tools in dermatology.

Current treatments for alopecia show no significant long-term benefits.

People with certain skin diseases often have more trouble understanding and describing their emotions, which can affect their health and treatment results.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

The document suggests medicine should integrate biological and cultural factors and focus on holistic, equitable care.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

UVB is good for a skin condition in Asian kids, a lotion works for head lice, a drug helps with a skin blistering disorder, a foam reduces itchiness in skin inflammation, birthmarks can be more widespread, and criteria for a neurocutaneous disorder were agreed upon.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The conference concluded with plans for joint research into children's skin conditions and emphasized the importance of collaboration and patient-focused research.

PRP is promising for skin, hair, and wound treatments but needs standardized methods and more research.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

Raising awareness about PCOS can improve women's quality of life.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Hair loss greatly lowers perceived health in both genders, and hair transplant surgery notably improves this.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

Choosing the right recall period for patient feedback is important for accurate data and depends on the disease, symptom changes, and patient impact.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Cannabis, cryotherapy, and scalp cooling can help improve the quality of life for chemotherapy patients.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Two new reliable Arabic questionnaires for measuring quality of life in women with PCOS were created, one for married and one for unmarried women.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.